Compound ID | 155
Class: Antibiofilm agent (nitazoxanide derivative)
| Spectrum of activity: | Gram-positive |
| Details of activity: | Clostridium difficile infections (CDI) |
| Propensity to select resistant mutants: | Yes |
| Institute where first reported: | Department of Medicine, Division of Infectious Diseases and International Health, University of Virginia, Charlottesville, Virginia, USA |
| Year first mentioned: | 2012 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| Chemical structure(s): | |||||||||||
|
|